Ascentis Independent Advisors

Position in ABBV — AbbVie Inc.

CIK 1845003 DALLAS, TX

Position in ABBV

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

$195,769

-$7,806,331 QoQ

Shares Held

778

-97.9% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

1.32%

of 13F equity value

Holder Rank

#3,959

of 4,145 holders

Holding Since

Jun 2021

17 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Ascentis Independent Advisors holds $465,945 across 9 Drug Manufacturers - General names. ABBV ranks #1 (42.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc. This page	778	$195,769
2	GILD	Gilead Sciences, Inc.	703	$88,811
3	NVS	Novartis AG	330	$51,717
4	JNJ	Johnson & Johnson	175	$44,443
5	MRK	Merck & Co., Inc.	300	$38,549
6	GSK	GSK plc	697	$36,536
7	SNY	Sanofi	144	$6,143
8	LLY	ELI LILLY & Co	3	$3,598

17 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$195,769	778	-97.9%	Shares	Sole	2026-08-04
2026-03-31	$8,002,100	36,793	+85.4%	Shares	Sole	2026-04-28
2025-12-31	$4,533,241	19,840	+16.0%	Shares	Sole	2026-01-29
2025-09-30	$3,960,491	17,105	-15.5%	Shares	Sole	2025-10-21
2025-06-30	$3,758,433	20,248	+0.3%	Shares	Sole	2025-07-14
2025-03-31	$4,230,418	20,191	-1.8%	Shares	Sole	2025-04-23
2024-12-31	$3,652,445	20,554	+24.2%	Shares	Sole	2025-01-24
2024-09-30	$3,267,109	16,544	-0.2%	Shares	Sole	2024-10-25
2024-06-30	$2,843,458	16,578	+0.0%	Shares	Sole	2024-07-29
2023-12-31	$2,568,317	16,573	-1.5%	Shares	Sole	2024-02-02
2023-09-30	$2,508,232	16,827	-1.1%	Shares	Sole	2023-10-20
2023-06-30	$2,291,622	17,009	+49.3%	Shares	Sole	2023-07-19
2023-03-31	$1,815,543	11,392	+66.0%	Shares	Sole	2023-06-01
2022-03-31	$1,112,723	6,864	+17.5%	Shares	Sole	2022-05-18
2021-12-31	$790,736	5,840	-39.5%	Shares	Sole	2022-02-11
2021-09-30	$1,040,837	9,649	+89.2%	Shares	Sole	2021-11-15
2021-06-30	$574,464	5,100	—	Shares	Sole	2021-08-12
No filing history on record for this holder in this stock.